AEX CONS DISCR/ QS0011016530
NLCG31/05/2024 14:02:45 | Chg. +14.75 | Open | High | Low | Previous Close |
---|---|---|---|---|---|
3,975.00XXP | +0.37% | 3,960.25 | 3,987.26 | 3,958.13 | 3,960.25 |
Newsfile Corp
14:11
Funded Capital Launches Revolutionary Financing Program for Ground-Up Constructions, Offering 100% F...
Newsfile Corp
14:08
Abitibi Metals Corp to Participate in THE Mining Investment Event of the North, Canada's Only Tier I...
GlobeNewswire
14:05
Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
14:00
Haoxi Health Technology Limited Reports Unaudited Financial Results for The Six Months Ended Decembe...
GlobeNewswire
14:00
Generation Lab Introduces First Platform that Measures Aging & Treatment Efficacy to Help Extend the...
GlobeNewswire
14:00
Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 ...
GlobeNewswire
14:00
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 i...
GlobeNewswire
14:00
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
GlobeNewswire
14:00
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
14:00
PodcastOne (Nasdaq: PODC) Appoints Wall Street Veteran Jon Merriman to Its Board of Directors
GlobeNewswire
14:00
ABM Named Among Barron’s 100 Most Sustainable Companies for Second Consecutive Year
GlobeNewswire
14:00
Iterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatm...